P929-0800 Screening compound: [1-(cyclopropylmethyl)-3-(methoxymethyl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl](3-thienyl)methanone

P929-0800 Screening compound: [1-(cyclopropylmethyl)-3-(methoxymethyl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl](3-thienyl)methanone
P929-0800 Screening compound: [1-(cyclopropylmethyl)-3-(methoxymethyl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl](3-thienyl)methanone alternative view

Chemical Structure Depiction of ChemDiv screening compound P929-0800
[1-(cyclopropylmethyl)-3-(methoxymethyl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl](3-thienyl)methanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P929-0800

Molecular Formula

C17H21N3O2S (C17 H21 N3 O2 S)

Compound Name

[1-(cyclopropylmethyl)-3-(methoxymethyl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl](3-thienyl)methanone

IUPAC name

1-(cyclopropylmethyl)-3-(methoxymethyl)-5-(thiophene-3-carbonyl)-1H4H5H6H7H-pyrazolo[43-c]pyridine

SMILES

COCc1nn(CC2CC2)c(CC2)c1CN2C(c1cscc1)=O

InChI

InChI=1S/C17H21N3O2S/c1-22-10-15-14-9-19(17(21)13-5-7-23-11-13)6-4-16(14)20(18-15)8-12-2-3-12/h5,7,11-12H,2-4,6,8-10H2,1H3

InChI Key

XOJASLYVWHTULJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27616071

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

331.44

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

1.626

Distribution Coefficient, logD

1.626

Water Solubility, LogSw

-2.17

Polar Surface Area

41.469

Acid Dissociation Constant (pKa)

21.89

Base Dissociation Constant (pKb)

1.66

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.94

P929-0800 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Hsp90-Targeted Library (11355 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with P929-0800 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P929-0800?
Check Price and Availability of P929-0800, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P929-0800 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P929-0800
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P929-0800
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P929-0800 available by request